RCDTF
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.75 | $716M | $92M |
| 2025 Q4 | 0.57 | $662M | $145M |
| 2025 Q3 | 0.53 | $632M | $137M |
| 2025 Q2 | 0.44 | $644M | $73M |
| 2025 Q1 | 0.61 | $680M | $156M |
| 2024 Q4 | 0.38 | $598M | -$699M |
| 2024 Q3 | 0.55 | $557M | $171M |
| 2024 Q2 | 0.49 | $578M | $105M |